🇺🇸 Epinephrin in United States

30 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 30

Most-reported reactions

1. Deep Vein Thrombosis — 5 reports (16.67%)
2. Pulmonary Embolism — 5 reports (16.67%)
3. Drug Hypersensitivity — 3 reports (10%)
4. Drug Interaction — 3 reports (10%)
5. Malaise — 3 reports (10%)
6. Syncope — 3 reports (10%)
7. Amnesia — 2 reports (6.67%)
8. Atrioventricular Block Second Degree — 2 reports (6.67%)
9. Cardiogenic Shock — 2 reports (6.67%)
10. Delirium — 2 reports (6.67%)

Source database →

Frequently asked questions

Is Epinephrin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Epinephrin in United States?

United States Naval Medical Center, San Diego is the originator. The local marketing authorisation holder may differ — check the official source linked above.